US Pharmaceutical Filtration Market Size, Share, Analysis, Trends, Growth, Forecasts, 2032

US Pharmaceutical Filtration Industry Prospective:

The US pharmaceutical filtration market size was worth around USD 4,781.09 million in 2023 and is predicted to grow to around USD 7,874.11 million by 2032 with a compound annual growth rate (CAGR) of roughly 5.70% between 2024 and 2032.

Request Free Sample

US Pharmaceutical Filtration Market: Overview

The US pharmaceutical filtration industry is a crucial sector for the healthcare and drug development industries of the US. Pharmaceutical filtration refers to the mechanical process through which contaminants are removed from gasses and liquids used during drug development and manufacturing processes. Filtration in the pharmaceutical sector ensures that the final developed product is free of microorganisms and contaminants thus meeting regulatory standards. The process involves the use of a porous medium for filtration. Additionally, pharmaceutical straining is a highly versatile process. It can be used for several pharmaceutical requirements. Depending on the solution being used, the pharmaceutical sector may have different filtration needs. The most common pharmaceutical filtration applications include surface filtration, cross-flow filtration, depth filtration, cake filtration, and ultrafiltration. Each process has specific advantages and performance value. The US pharmaceutical filtration industry is likely to develop several new growth opportunities as the country expands its production base to other nations. However, the cost of equipment installation and validation may impact the regional market growth trend.

Key Insights:

• As per the analysis shared by our research analyst, the US pharmaceutical filtration market is estimated to grow annually at a CAGR of around 5.70% over the forecast period (2024-2032)
• In terms of revenue, the US pharmaceutical filtration market size was valued at around USD 4,781.09 million in 2023 and is projected to reach USD 7,874.11 million, by 2032.
• The US pharmaceutical filtration market is projected to grow at a significant rate due to the growing demand for medicinal drugs across the country
• Based on the application, the final product processing segment is growing at a high rate and will continue to dominate the regional market as per industry projection
• Based on the product, the membrane filters segment is anticipated to command the largest market share
• Based on region, Eastern and western regions are projected to dominate the regional market during the forecast period

Request Free Sample

US Pharmaceutical Filtration Market: Growth Drivers

Growing demand for medicinal drugs across the country will drive the market revenue rate

The US pharmaceutical filtration market is expected to grow due to the rising demand for medicinal drugs in the country. The US healthcare infrastructure is one of the world’s most renowned and technologically advanced medical care systems. Apart from managing the health of the regional population, the country is well known for international medical tourism. For instance, the US is considered the best country for advanced cancer treatment. In September 2023, the United States government announced an investment of USD 240 million for cancer research. The money will be used for research on cancer diagnosis, prevention, and management. In June 2024, St Charles Health System, a hospital and health company, announced the expansion of its cancer treatment healthcare facility. The company broke ground for a new cancer center located in the Redmond area. The facility is expected to serve over 300 cancer patients per day. In June 2024, another firm Cleveland Clinic Hillcrest Hospital announced the inauguration of Lozick Cancer Pavilion. The inauguration marked the addition of 10,600-square-foot to the hospital’s current cancer center infrastructure.

Surging investments in the development of new drugs in the US will promote the adoption of filtration techniques

The US is a leading country in terms of new drug research and development. The US pharmaceutical industry has been pivotal in innovating cures for several diseases that affect the global population. It continues to invest in novel drug studies and innovation. For instance, in July 2024, the Joint United Nations Program on HIV/AIDS (UNAIDS) announced the trial release of the US-based Gilead Sciences biopharmaceutical company. As per the trial results, two-yearly injections of Lenacapavir have shown exceptional proficiency in preventing the Human immunodeficiency virus (HIV) as compared to other forms of oral preventives. In March 2022, the US Food & Drugs Administration (FDA) authority announced the approval of a first-in-class and unique drug called tripeptide (Mounjaro) for the treatment of type-2 disease. The medical condition affects nearly 95% of people among the 38 million people in the US with diabetes. Such advancements are expected to fuel the demand for the US pharmaceutical filtration market.

US Pharmaceutical Filtration Market: Restraints

High cost of installation and further validation may limit the industry’s growth rate

The growth in the US industry for pharmaceutical filtration is expected to be restricted due to the high cost of installation of comprehensive filtration equipment and processes. For instance, exceptionally advanced filtration systems may cost between USD 50,000 to USD 210,000. Additionally, these equipment must be validated to ensure compliance with the regulatory framework. Validation cost includes several points starting from the development of the validation plan and including parameters such as performance qualification, installation qualification, and documentation. The final cost of validation on average is between USD 50,000 to USD 100,000.

US Pharmaceutical Filtration Market: Opportunities

Growing advancements in filtration technology may generate massive growth opportunities

The US pharmaceutical filtration market is projected to generate growth opportunities due to the growing advancements in filtration technology and technique. For instance, US-based multinational Conglomerate, 3M Company announced an investment of USD 150 million in May 2023. The company is expected to use the investment for advanced filtration techniques in biopharmaceuticals. 3M has invested the money in the European market. It will create around 60 full-time positions along with equipment and facility improvements. In June 2024, Cytiva, a part of the US-based Danaher Group and a leading global life sciences company announced the extension of its filtration profile. The company is set to address problems faced by companies producing high-concentration biological drugs. Cytiva introduced novel Supor Prime sterilizing grade filters that deliver higher yields, limit the cost of filtration-based losses, and reduce any form of premature blockage. In addition to this, the introduction of Artificial Intelligence (AI) technology in filtration techniques can further help the market players deliver exceptional performance. AI can be leveraged to automate repetitive tasks. Moreover, the technology can be used for quality control and data analysis.

US Pharmaceutical Filtration Market: Challenges

Stringent regulations governing filtration technology may challenge the market expansion rate

The industry for pharmaceutical filtration in the US is expected to be challenged by the presence of a stringent regulatory environment. The industry is governed by multiple agencies including FDA, Occupational Safety and Health Administration (OSHA), Centers for Disease Control and Prevention (CDC), and Pharmacopeia (USP). Adhering to each regulatory profile may be challenging for the industry players.

US Pharmaceutical Filtration Market: Segmentation

The US pharmaceutical filtration market is segmented based on application, technology, product, and region.

Based on the application, the regional market divisions are raw material filtration, final product processing, cell separation, air filtration, and others. In 2023, the highest growth was observed in the final product processing segment. This step is critical for the drugs to meet regulatory standards as it consists of the sterile filtration process which is crucial during drug manufacturing. Additionally, raw material filtration and air filtration are factors that cannot be compromised. Generally, a company can suffer a loss ranging from USD 5 million to USD 100 million in case of failed trials.

Based on technology, the US pharmaceutical filtration industry is fragmented into nanofiltration, ultrafiltration, microfiltration, and others.

Based on the product, the US pharmaceutical filtration industry is divided into filtration accessories, filter holders, membrane filters, and others. In 2023, the highest growth rate was registered in the membrane filters segment. The product is used across drug production stages. They ensure product purity which is essential for all drugs to pass clinical trials. Sterile membrane filters generally cost between USD 50 to USD 320 per membrane. The demand for filter holders and filtration accessories is significantly high.

US Pharmaceutical Filtration Market: Report Scope

US Pharmaceutical Filtration Market: Regional Analysis

Eastern and Western regions to continue adding revenue in the US market

The US pharmaceutical filtration market will be led by prominent eastern and western states. Some of the leading regions that are expected to contribute heavily to the US sector are New York, Boston, Washington, D.C. Area, North Carolina, Texas, Philadelphia, and California. These regions are home to leading drug-developing companies and facilities. In July 2024, Artelo Biosciences announced that it had received FDA approval for its latest development in the pharmaceutical field. The company has identified new Fatty Acid Binding Proteins (FABPs) that have the potential to treat inflammation, pain, and cancer. Artelo Biosciences is backed by Stony Brook University and the Research Foundation for the State University of New York. In May 2024, Georgia-based Emory School of Medicine announced the launch of a new project. The medicine school is working on developing a novel drug discovery pipeline that could be used as next-generation life-saving medicines. In July 2024, reports emerged suggesting that pharmaceutical giants such as Pfizer, Jhonson & Jhonson, and Eli Lilly were launching new biotech incubator initiatives in San Diego. The move will help the companies establish their strength in the regional drug development industry.

US Pharmaceutical Filtration Market: Competitive Analysis

The US pharmaceutical filtration market is led by players like:

• Donaldson Company
• GE Healthcare Life Sciences
• Amazon Filters
• Merck Millipore
• Graver Technologies
• Thermo Fisher Scientific
• Pall Corporation
• Meissner Filtration Products
• Parker Hannifin
• Porvair Filtration Group
• 3M Health Care
• Novasep
• Sartorius Stedim Biotech
• Sterlitech Corporation
• Eaton Filtration.

The US pharmaceutical filtration market is segmented as follows:

By Application

• Raw Material Filtration
• Final Product Processing
• Cell Separation
• Air Filtration
• Others

By Technology

• Nanofiltration
• Ultrafiltration
• Microfiltration
• Others

 By Product

•  Filtration Accessories
•  Filter Holders
•  Membrane Filters
•  Others

By Region

The U.S.

• Northeast
• Midwest
• South
• West